AMALY — SHARIAH COMPLIANCE REPORT ================================== Symbol: RLYB Report Date: 2026-05-04 Full Report: https://amaly.io/stock/RLYB EXECUTIVE SUMMARY ------------------ Compliance Status: NON_COMPLIANT Quality Rating: B Description: Rallybio Corporation (RLYB), a clinical-stage biotechnology company focused on developing therapies for severe and rare diseases, demonstrates a permissible core business model under Shariah principles. However, its financial metrics, particularly the high liquidity ratio (212.44%) and interest income ratio (427.83%), result in non-compliance across major screening standards due to excessive exposure to riba (interest). The company maintains low debt levels (0.45%), which is compliant, and no non-permissible business activities. Despite strong ESG alignment with low risk in environmental, social, and governance factors, the overall compliance status is determined by index exclusion. Investors may consider monitoring for potential financial restructuring to achieve compliance, with purification required for any impure income. Primary Compliance Concerns: - High liquidity ratio (212.44%) exceeding thresholds, indicating excessive cash holdings generating interest - Elevated interest income ratio (427.83%) due to low revenue base in pre-commercial stage Purification Requirement: 427.83% Index Inclusion: Not included in S&P Dow Jones Shariah, MSCI Islamic, FTSE Shariah, or DJIM indices KEY FINANCIAL METRICS ---------------------- Debt Ratio: 0.0% Liquidity Ratio: 2.1% Interest Income Ratio: 4.3% Purification Required: 0.00% INDEX INCLUSION STATUS ----------------------- S&P Shariah: EXCLUDED MSCI Islamic: EXCLUDED DJIM: EXCLUDED FTSE Shariah: EXCLUDED Total: 0 of 4 Last Verified: 2026-01-31 REPORTING PERIOD ----------------- Latest Annual Report: FY 2025 Latest Quarterly Data: Q4 2025 Trend Period: FY 2021 to FY 2025 Data Retrieved: 2026-02-28T12:00:00Z --- Full interactive report: https://amaly.io/stock/RLYB Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.